Access to Cancer Treatment in Non-Metropolitan Areas of Australia

Access to Cancer Treatment in Non-Metropolitan Areas of Australia

Access to cancer treatment in non-metropolitan areas of Australia Amgen Australia Pty Ltd September 2011 Access to cancer treatment in Australia Contents Glossary ...........................................................................................................................................i Executive Summary .........................................................................................................................i 1 An overview of cancer ........................................................................................................ 8 1.1 What is cancer? ...................................................................................................................... 8 1.2 Prostate and breast cancer .................................................................................................... 9 2 A literature review on access to cancer treatment .......................................................... 13 2.1 Variations in cancer epidemiology ....................................................................................... 13 2.2 Access to cancer treatment ................................................................................................. 17 2.3 Improving access to cancer treatment ................................................................................ 19 3 Mapping access to cancer treatment ............................................................................... 21 3.1 Incidence of breast and prostate cancer ............................................................................. 21 3.2 Hospitals that deliver cancer treatment .............................................................................. 25 3.3 Average distance to cancer treatment ................................................................................ 44 4 Focusing on specific FEDs.................................................................................................. 50 4.1 Choosing FEDs ...................................................................................................................... 50 4.2 Postcodes with the greatest distance to cancer treatment ................................................. 53 4.3 Potential improvements in providing cancer treatment ..................................................... 56 References ................................................................................................................................... 63 Appendix A – Estimated number of new cancer cases ............................................................... 67 Appendix B - Hospitals offering cancer treatment ...................................................................... 69 Appendix C – Distance versus population among postcodes ..................................................... 78 Limitation of our work..................................................................................................................... 81 Charts Chart 1.1 : Incidence and mortality rates for breast cancer in females ..................................... 10 Chart 1.2 : Incidence and mortality rates for prostate cancer ................................................... 10 Chart 2.1 : Proportion of resident population by remoteness areas ......................................... 16 Chart 2.2 : Proportion of cancer patients who receive treatment, by type ............................... 16 Tables Table 1.1 : Estimated leading causes of the cancer burden of disease ........................................ 9 Table 1.2 : Hospitalisations with a principal diagnosis of cancer, 2008-09 ................................ 11 Table 2.1 : Incidence and mortality of prostate and breast cancer, by remoteness 2003-07 .... 14 Table 3.1 : Estimated breast and prostate cancer incidence rates, by state/territory .............. 21 Table 3.2 : Estimated breast and prostate cancer incidence rates, by age and gender, 2011 .. 22 Table 3.3 : Estimated number of new cases of breast and prostate cancer, 2011 .................... 23 Table 3.4 : Estimated average distance to cancer-related infusion services, by state/territory 45 Table 3.5 : Estimated average distance to radiotherapy services, by state/territory ................ 45 Table 3.6 : Estimated average distance to cancer-related infusion services, by FED ................ 46 Table 3.6 : Estimated average distance to cancer-related infusion services, by FED continued 47 Table 3.7 : Estimated average distance to radiotherapy services, by FED ................................. 47 Table 3.7 : Estimated average distance to radiotherapy services, by FED continued ............... 48 Table 4.1 : Average distance to cancer treatment and estimated number of new cancer cases for selected FEDs ......................................................................................................................... 52 Table 4.2 : The five furthest postcodes to cancer-related infusion services, by selected FEDs . 54 Table 4.3 : The five furthest postcodes to cancer-related infusion services, by selected FED continued ............................................................................................................................. 55 Table 4.4 : Distance to nearest GP versus distance to nearest cancer-related infusion service 58 Table A.1 : Estimated number of new breast and prostate cancer cases by FEDs, 2011 .......... 67 Table B.1 : Planned cancer treatment sites by state/territory................................................... 69 Table B.2 : Hospitals offering cancer-related infusion services in Australia .............................. 69 Table B.3 : Hospitals offering radiotherapy services in Australia ............................................... 77 Table C.1 : Distance to nearest cancer-related infusion service versus population of postcode78 Figures Figure 3.1 : Estimated number of new cases of breast and prostate cancer by FEDs, 2011 ..... 24 Figure 3.2 : Location of radiotherapy and cancer-related infusion services across Australia ... 28 Figure 3.3 : Incidence of breast and prostate cancer compared to location of cancer treatment in Australia, 2011 ........................................................................................................................ 30 Figure 3.4 : Incidence of breast and prostate cancer compared to location of cancer treatment in ACT, 2011 ................................................................................................................................ 31 Figure 3.5 : Incidence of breast and prostate cancer compared to location of cancer treatment in NSW, 2011 ............................................................................................................................... 32 Figure 3.6 : Incidence of breast and prostate cancer compared to location of cancer treatment in Sydney, 2011 ........................................................................................................................... 33 Figure 3.7 : Incidence of breast and prostate cancer compared to location of cancer treatment in Northern Territory, 2011 ......................................................................................................... 34 Figure 3.8 : Incidence of breast and prostate cancer compared to location of cancer treatment in Queensland, 2011 ................................................................................................................... 35 Deloitte Access Economics Figure 3.9 : Incidence of breast and prostate cancer compared to location of cancer treatment in Brisbane, 2011 ......................................................................................................................... 36 Figure 3.10 : Incidence of breast and prostate cancer compared to location of cancer treatment in South Australia, 2011 ............................................................................................. 37 Figure 3.11 : Incidence of breast and prostate cancer compared to location of cancer treatment in Adelaide, 2011 ....................................................................................................... 38 Figure 3.12 : Incidence of breast and prostate cancer compared to location of cancer treatment in Tasmania, 2011 ...................................................................................................... 39 Figure 3.13 : Incidence of breast and prostate cancer compared to location of cancer treatment in Victoria, 2011 ......................................................................................................... 40 Figure 3.14 : Incidence of breast and prostate cancer compared to location of cancer treatment in Melbourne, 2011 ................................................................................................... 41 Figure 3.15 : Incidence of breast and prostate cancer compared to location of cancer treatment in Western Australia, 2011 ........................................................................................ 42 Figure 3.16 : Incidence of breast and prostate cancer compared to location of cancer treatment in Perth, 2011 ............................................................................................................ 43 Figure 4.1 : Map of selected FEDs .............................................................................................. 51 Deloitte Access Economics Access to cancer treatment in Australia Glossary ABS Australian Bureau of Statistics AEC Australian Electoral Commission AIHW Australian Institute of Health

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    87 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us